Leqembi, along with rare disease and depression treatments, helped offset a year-over-year decline in revenue for the company’s multiple sclerosis products.
Related Posts
Software startup Rippling sues competitor Deel, claiming a spy carried out ‘corporate espionage’
Rippling unknowingly hired a person who downloaded internal records and met with leadership at competitor Deel, the lawsuit claims.
Hyundai reveals all-electric Ioniq 9 three-row SUV
Hyundai Motor’s newest all-electric vehicle is the 2026 Ioniq 9 SUV a three-row, up to seven-passenger SUV for the U.S. market.
Spirit Airlines cuts 200 jobs in bankruptcy cost-cutting scramble
Spirit Airlines cuts 200 jobs across the airline as it seeks to exit bankruptcy protection this quarter.